Form 4: PAVmed Inc. Director Agrawal Acquires Shares

PAVmed Inc. reports that Director Sundeep Agrawal acquired 13,930 shares of common stock on April 2, 2026, as part of a restricted stock grant.

Summary

• Sundeep Agrawal, a Director at PAVmed Inc., acquired 13,930 shares of common stock on April 2, 2026.
• This acquisition was made through a restricted stock grant under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2029, and is subject to forfeiture if the service period is not completed.
• Following this transaction, Agrawal beneficially owns 19,337 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider stock grants can be positive, this is a routine disclosure of a restricted stock award with a distant vesting date and no immediate financial impact or strategic update.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The grant of restricted stock aligns management's interests with long-term shareholder value.

Risks

• The restricted stock is subject to forfeiture if the requisite service period is not completed, indicating potential loss of awarded shares for the director.
• The vesting date is May 20, 2029, meaning the shares are not fully available to the director for several years.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider stock grants, as reported in Form 4 filings, are common in the biotechnology and healthcare sectors where PAVmed Inc. operates. These grants are often used to attract and retain key talent and align executive compensation with long-term company performance.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but the restricted nature and distant vesting date limit immediate impact.
• Employees: The grant highlights the company's use of equity-based compensation to incentivize management.
• Management: The director receives a long-term incentive tied to continued service and company performance.

Key Dates

Keywords

PAVmed Inc., PAVM, Form 4, Insider Trading, Restricted Stock, Equity Grant, Director, Beneficial Ownership, Securities Exchange Act